NCS Multistage (NCSM) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
30 Apr, 2026Strategic positioning and market overview
Holds a leadership position in well construction and completion technologies, enabling capital-efficient unconventional resource development in high-growth markets worldwide.
Revenue is geographically diversified: 52% Canada, 38% U.S., and 10% international.
Product mix is 70% products and 30% services, serving over 230 customers.
Addressable global completion equipment market estimated at $9.7B in 2026, with North America representing 46%.
Well-positioned to expand from a ~2% share of the global market, leveraging technology and international expansion.
Product and service portfolio
Offers fracturing systems, tracer diagnostics, well construction solutions, and plug-and-perf products through a joint venture.
Proprietary technologies support complex well installations and enhanced recovery.
Tracer diagnostics optimize well spacing, completion design, and flow assurance.
Repeat Precision joint venture provides composite and dissolvable plugs, setting tools, and perforating guns.
Technologies are applicable in both onshore and offshore, including geothermal and SAGD applications.
Financial performance and guidance
Q1 2026 revenue was $45.6M, down 9% year-over-year; U.S. revenue more than doubled to $19.1M, international up 13%.
Adjusted gross margin for Q1 2026 was 40%, with adjusted EBITDA of $5.6M.
Full-year 2026 revenue guidance is $186–$194M, with adjusted EBITDA of $26–$29M and free cash flow after distributions of $11–$15M.
Consistently converts 50–70% of adjusted EBITDA to free cash flow, supported by a capital-light model.
Return on invested capital improved to 11.2% in 2025, with a target of 15%+.
Latest events from NCS Multistage
- Q1 2026 revenue fell 8.7–9%, but U.S. growth and strong 2026 outlook signal resilience.NCSM
Q1 202630 Apr 2026 - Expanding globally with innovative completions technology and disciplined capital allocation.NCSM
Lytham Partners 2026 Industrials & Basic Materials Summit22 Apr 2026 - Shareholders will vote on directors, auditor ratification, and executive pay, with robust governance in place.NCSM
Proxy filing2 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.NCSM
Proxy filing2 Apr 2026 - 2025 delivered double-digit revenue and EBITDA growth, with 2026 guidance projecting further gains.NCSM
Q4 20256 Mar 2026 - Q2 2024 revenue up 17% with improved margins and raised 2024 guidance on strong international growth.NCSM
Q2 20242 Feb 2026 - Q3 2024 revenue up 15% year-over-year, with strong global demand and margin expansion.NCSM
Q3 202417 Jan 2026 - Strong 2024 growth, innovation, and international expansion drive robust margins and free cash flow.NCSM
Emerging Growth Virtual Conference27 Dec 2025 - Record international growth, margin expansion, and strong cash position highlight 2024 results.NCSM
Q4 202425 Dec 2025